PMID- 34458338 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210831 IS - 2297-055X (Print) IS - 2297-055X (Electronic) IS - 2297-055X (Linking) VI - 8 DP - 2021 TI - Effect of SYTL3-SLC22A3 Variants, Their Haplotypes, and G x E Interactions on Serum Lipid Levels and the Risk of Coronary Artery Disease and Ischaemic Stroke. PG - 713068 LID - 10.3389/fcvm.2021.713068 [doi] LID - 713068 AB - Background: The current study aimed to investigate the effects of synaptotagmin-like 3 (SYTL3) and solute carrier family 22 member 3 (SLC22A3) single nucleotide polymorphisms (SNPs) and gene-environment (G x E) interactions on blood lipid levels as well as the risk of coronary artery disease (CAD) and ischaemic stroke (IS) in the Southern Chinese Han population. Methods: The genetic makeup of 6 SYTL3-SLC22A3 SNPs in 2269 unrelated participants (controls, 755; CAD, 758 and IS, 756) of Chinese Han ethnicity was detected by the next-generation sequencing techniques. Results: The allele and genotype frequencies of the SYTL3 rs2129209 and SLC22A3 rs539298 SNPs were significantly different between the case and control groups. The SLC22A3 rs539298 SNP was correlated with total cholesterol (TC) levels in controls, the rs539298G allele carriers maintained lower TC levels than the rs539298G allele non-carriers. At the same time, the SLC22A3 rs539298 SNP interacted with alcohol consumption reduced the risk of CAD and IS. The SYTL3-SLC22A3 A-C-A-A-A-A, G-T-C-G-C-A and A-T-A-A-C-A haplotypes increased and the A-C-A-A-C-G haplotype reduced the risk of CAD, whereas the SYTL3-SLC22A3 A-C-A-A-A-A, G-T-C-G-A-G and A-T-A-A-C-A haplotypes increased and the A-C-A-A-A-G and A-C-A-A-C-G haplotypes reduced the risk of IS. In addition, several SNPs interacted with alcohol consumption, body mass index >/= 24 kg/m(2) and cigarette smoking to affect serum lipid parameters such as triglyceride, high-density lipoprotein cholesterol, TC, and apolipoprotein A1 levels. Conclusions: Several SYTL3-SLC22A3 variants, especially the rs539298 SNP, several haplotypes, and G x E interactions, were related to blood lipid parameters and the risk of CAD and IS in the Southern Chinese Han population. CI - Copyright (c) 2021 Zheng, Yin, Cao, Chen, Wu and Huang. FAU - Zheng, Peng-Fei AU - Zheng PF AD - Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning, China. FAU - Yin, Rui-Xing AU - Yin RX AD - Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning, China. FAU - Cao, Xiao-Li AU - Cao XL AD - Department of Neurology, The First Affiliated Hospital, Guangxi Medical University, Nanning, China. FAU - Chen, Wu-Xian AU - Chen WX AD - Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning, China. FAU - Wu, Jin-Zhen AU - Wu JZ AD - Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning, China. FAU - Huang, Feng AU - Huang F AD - Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning, China. LA - eng PT - Journal Article DEP - 20210812 PL - Switzerland TA - Front Cardiovasc Med JT - Frontiers in cardiovascular medicine JID - 101653388 PMC - PMC8387813 OTO - NOTNLM OT - SLC22A3 OT - SYTL3 OT - coronary artery disease OT - haplotype OT - ischaemic stroke OT - lipids OT - single nucleotide polymorphism COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/08/31 06:00 MHDA- 2021/08/31 06:01 PMCR- 2021/01/01 CRDT- 2021/08/30 06:02 PHST- 2021/05/21 00:00 [received] PHST- 2021/07/21 00:00 [accepted] PHST- 2021/08/30 06:02 [entrez] PHST- 2021/08/31 06:00 [pubmed] PHST- 2021/08/31 06:01 [medline] PHST- 2021/01/01 00:00 [pmc-release] AID - 10.3389/fcvm.2021.713068 [doi] PST - epublish SO - Front Cardiovasc Med. 2021 Aug 12;8:713068. doi: 10.3389/fcvm.2021.713068. eCollection 2021.